These are animal vaccines. None of them is a vaccine for people. Every product on these pages is authorised for the animal species named in its row, by the UK Veterinary Medicines Directorate. A product licensed for cattle or poultry says nothing about whether protection exists for a person, and several of these viruses do not infect people at all.
Looking for human vaccines? Use the main Virus Navigator.
At a glance
| Abbreviation | CPV |
|---|---|
| ICTV species | Protoparvovirus carnivoran1 |
| Family | Parvoviridae |
| Baltimore class | II — ssDNA |
| Human infection | Not known to infect humans |
Also called: Carnivore protoparvovirus 1; Protoparvovirus carnivoran 1; Protoparvovirus carnivoran1
Floreoviria › Cossaviricota › Quintoviricetes › Piccovirales › Parvoviridae › Protoparvovirus
What it is
Taxonomy copied from ICTV MSL41.v1 / VMR_MSL41.v1.20260729.xlsx. These ranks are not hand-edited; a correction means re-running the fetch against a newer release.
| Realm | Floreoviria |
|---|---|
| Kingdom | Shotokuvirae |
| Phylum | Cossaviricota |
| Class | Quintoviricetes |
| Order | Piccovirales |
| Family | Parvoviridae |
| Subfamily | Parvovirinae |
| Genus | Protoparvovirus |
| ICTV identifier | ICTV20132614 |
| NCBI taxon | 3052707 |
| Exemplar isolate | M19296 |
Host evidence
- dog: 2,894 GenBank records
- cat: 632 GenBank records
Counts of nucleotide records annotated with that host. Evidence of provenance, not a statement of host range.
Where it occurs
Not searched yet. No country-level occurrence data has been curated for this virus. The WHO reported-case data on this site covers a limited set of diseases; a virus outside it gets no map rather than an empty one.
What it does
Not searched yet. Burden, severity and transmissibility figures have not been curated for this virus yet. When they are, each will carry the exact sentence from its source.
Vaccines
| Name | Developer | Platform | Use | Stage | Jurisdictions | Trials | Source |
|---|---|---|---|---|---|---|---|
| Canigen DHP Lyophilisate and Solvent for Suspension for Injection for Dogs | Intervet International B.V. | live attenuated | Routine immunisation | Approved | UK: approved | — | VMD product A006702 (VM 06376/4114); active substance 'Canine parvovir |
| Canigen DHPPi Lyophilisate for Suspension for Injection for Dogs | Intervet International B.V. | live attenuated | Routine immunisation | Approved | UK: approved | — | VMD product A003500 (VM 06376/4107); active substance 'Canine parvovir |
| Canigen Parvo-C Lyophilisate for Suspension for Injection for Dogs | Intervet International B.V. | live attenuated | Routine immunisation | Approved | UK: approved | — | VMD product A007027 (VM 06376/4108); active substance 'Canine parvovir |
| Canixin DHPPi Lyophilisate and Solvent for Suspension for Injection for Dogs | Virbac | live attenuated | Routine immunisation | Approved | UK: approved | — | VMD product A011494 (VM 05653/3067); active substance 'Canine parvovir |
| Canixin DHPPi/L | VIRBAC | Not searched yet | Routine immunisation | Approved | UK: approved | — | VMD product A011495 (VM 05653/3023); active substance 'Canine parvovir |
| CANIXIN DHPPi/L Lyophilisate and Suspension for Suspension for Injection for Dogs | Virbac | Not searched yet | Routine immunisation | Approved | UK: approved | — | VMD product A008317 (VM 05653/5054); active substance 'Canine parvovir |
| Eurican DAP Lyophilisate and Solvent for Suspension for Injection | Boehringer Ingelheim Animal Health UK Limited | live attenuated | Routine immunisation | Approved | UK: approved | — | VMD product A009494 (VM 08327/5023); active substance 'Canine parvovir |
| Eurican DAPPi Lyophilisate and Solvent for Suspension for Injection | Boehringer Ingelheim Animal Health UK Limited | live attenuated | Routine immunisation | Approved | UK: approved | — | VMD product A009495 (VM 08327/5024); active substance 'Canine parvovir |
| Eurican DHPPi Lyophilisate for Suspension for Injection | Boehringer Ingelheim Animal Health UK Limited | live attenuated | Routine immunisation | Approved | UK: approved | — | VMD product A002697 (VM 08327/5053); active substance 'Canine parvovir |
| Feligen RCP | Virbac | live attenuated | Routine immunisation | Approved | UK: approved | — | VMD product A001572 (VM 05653/4048); active substance 'Feline panleuko |
| Leucofeligen FeLV/RCP Lyophilisate and Solvent for Suspension for Injection for Cats | Virbac | Not searched yet | Routine immunisation | Approved | UK: approved | — | VMD product A007290 (VM 05653/5013); active substance 'Feline panleuko |
| Nobivac DHP | Intervet International B.V. | live attenuated | Routine immunisation | Approved | UK: approved | — | VMD product A012179 (VM 06376/3036); active substance 'Canine parvovir |
| Nobivac DHPPi, Lyophilisate for Suspension for Injection for Dogs | Intervet International B.V. | live attenuated | Routine immunisation | Approved | UK: approved | — | VMD product A001797 (VM 06376/4104); active substance 'Canine parvovir |
| Nobivac DP PLUS Lyophilisate and Solvent for Suspension for Injection for Puppies | Intervet International B.V. | live attenuated | Routine immunisation | Approved | UK: approved | — | VMD product A011079 (VM EU/2/20/265/001-002); active substance 'Canine |
| Nobivac NXT HCP Lyophilisate and Solvent for Suspension for Injection for Cats | Intervet International B.V. | live attenuated | Routine immunisation | Approved | UK: approved | — | VMD product A014136 (VM EU/2/26/369/001-002); active substance 'Feline |
| Nobivac NXT HCPCh Lyophilisate and Solvent for Suspension for Injection for Cats | Intervet International B.V. | Not searched yet | Routine immunisation | Approved | UK: approved | — | VMD product A014904 (VM EU/2/26/368/001-002); active substance 'Feline |
| Nobivac NXT HCPChFeLV, Lyophilisate and Solvent for Suspension for Injection, for Cats | Intervet International B.V. | Not searched yet | Routine immunisation | Approved | UK: approved | — | VMD product A014010 (VM EU/2/26/365/001-002); active substance 'Feline |
| Nobivac NXT HCPFeLV Lyophilisate and Solvent for Suspension for Injection for Cats | Intervet International B.V. | live attenuated | Routine immunisation | Approved | UK: approved | — | VMD product A014906 (VM EU/2/26/366/001-002); active substance 'Feline |
| Nobivac Parvo-C Lyophilisate for Suspension for Injection for Dogs | Intervet International B.V. | live attenuated | Routine immunisation | Approved | UK: approved | — | VMD product A001602 (VM 06376/4105); active substance 'Canine parvovir |
| Nobivac Tricat Trio, Lyophilisate and Solvent for Suspension for Injection for Cats | Intervet International B.V. | live attenuated | Routine immunisation | Approved | UK: approved | — | VMD product A012185 (VM 06376/3015); active substance 'Feline panleuko |
| Purevax RCP | Boehringer Ingelheim Vetmedica GmbH | Not searched yet | Routine immunisation | Approved | UK: approved | — | VMD product A011138 (VM EU/2/04/052/001-004); active substance 'Feline |
| Purevax RCP FeLV | Boehringer Ingelheim Vetmedica GmbH | Not searched yet | Routine immunisation | Approved | UK: approved | — | VMD product A011139 (VM EU/2/04/048/001-004); active substance 'Feline |
| Purevax RCP FeLV Lyophilisate and Solvent for Suspension for Injection | Boehringer Ingelheim Vetmedica GmbH | Not searched yet | Routine immunisation | Approved | UK: approved | — | VMD product A006214 (VM 61700/5069); active substance 'Feline panleuko |
| Purevax RCP Lyophilisate and Solvent for Suspension for Injection | Boehringer Ingelheim Vetmedica GmbH | Not searched yet | Routine immunisation | Approved | UK: approved | — | VMD product A006251 (VM 61700/5070); active substance 'Feline panleuko |
| Purevax RCPCh | Boehringer Ingelheim Vetmedica GmbH | Not searched yet | Routine immunisation | Approved | UK: approved | — | VMD product A011140 (VM EU/2/04/050/001-004); active substance 'Feline |
| Purevax RCPCh FeLV | Boehringer Ingelheim Vetmedica GmbH | Not searched yet | Routine immunisation | Approved | UK: approved | — | VMD product A011141 (VM EU/2/04/047/001-004); active substance 'Feline |
| Purevax RCPCh FeLV Lyophilisate and Solvent for Suspension for Injection | Boehringer Ingelheim Vetmedica GmbH | Not searched yet | Routine immunisation | Approved | UK: approved | — | VMD product A006188 (VM 61700/5071); active substance 'Feline panleuko |
| Purevax RCPCh Lyophilisate and Solvent for Suspension for Injection | Boehringer Ingelheim Vetmedica GmbH | Not searched yet | Routine immunisation | Approved | UK: approved | — | VMD product A006215 (VM 61700/5072); active substance 'Feline panleuko |
| Vanguard 7 | Zoetis UK Limited | Not searched yet | Routine immunisation | Approved | UK: approved | — | VMD product A002548 (VM 42058/5178); active substance 'Canine parvovir |
| Vanguard CPV Suspension for Injection | Zoetis UK Limited | live attenuated | Routine immunisation | Approved | UK: approved | — | VMD product A002527 (VM 42058/5179); active substance 'Canine parvovir |
| Vanguard CPV-L | Zoetis UK Limited | Not searched yet | Routine immunisation | Approved | UK: approved | — | VMD product A002528 (VM 42058/5180); active substance 'Canine parvovir |
| Versican Plus DHPPi Lyophilisate and Solvent for Suspension for Injection for Dogs | Zoetis UK Limited | live attenuated | Routine immunisation | Approved | UK: approved | — | VMD product A008842 (VM 42058/5082); active substance 'Canine parvovir |
| Versican plus DHPPi/L4 | Zoetis Belgium | Not searched yet | Routine immunisation | Approved | UK: approved | — | VMD product A011245 (VM EU/2/14/164/001-002); active substance 'Canine |
| Versican Plus DHPPi/L4 Lyophilisate and Suspension for Suspension for Injection for Dogs | Zoetis UK Limited | Not searched yet | Routine immunisation | Approved | UK: approved | — | VMD product A008812 (VM 42058/5083); active substance 'Canine parvovir |
| Versican Plus DHPPi/L4R Lyophilisate and Suspension for Suspension for Injection for Dogs | Zoetis UK Limited | Not searched yet | Routine immunisation | Approved | UK: approved | — | VMD product A008768 (VM 42058/5081); active substance 'Canine parvovir |
| Versifel CVR | Zoetis UK Limited | live attenuated | Routine immunisation | Approved | UK: approved | — | VMD product A007740 (VM 42058/5187); active substance 'Feline panleuko |
Antivirals
Not searched yet. No US-approved antiviral for this virus was found in the openFDA drug label endpoint. Only US labels were searched, and only drugs the FDA classes as antivirals.
Antibodies and immune globulins
Not searched yet. No US-approved antiviral antibody for this virus was found in the openFDA drug label endpoint.
Approval status is not a treatment recommendation. Dosing and eligibility are on the label and in national guidelines. This page does not give medical advice and does not render dosing. A development stage is not a measure of how well something works.